Lot 1
No lot description published.
Buyer: NHS England →
Project title: NHS National Framework for Omalizumab commencing 1st February 2026 Offer reference number: CM/TNS/25/5734 Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
No lot description published.
No usable CPV category has been published, so a comparable market set cannot yet be built.
No planning milestones published.
No linked framework, prior procurement or reprocurement published.
Diagnostic view. “Not published” means this current release does not provide a value.
| OCID | ocds-h6vhtk-058e04 |
|---|---|
| Latest release ID | 086501-2025 |
| Latest release timestamp | Tue Dec 30 2025 16:29:54 GMT+0000 (Coordinated Universal Time) |
| Source | find-a-tender |
| Official notice URL | Not published |
| Tender status | complete |
| Procurement method | open |
| Procurement method details | Open procedure |
| Main procurement category | Not published |
| Above threshold | Not published |
| Legal basis | 2023/54 |
| Tender period: start | Not published |
| Tender period: end | Not published |
| Expression of interest deadline | Not published |
| Enquiry deadline | Not published |
| Award period: start | Not published |
| Award period: end | Not published |
| Submission method details | Not published |
| Submission languages | Not published |
| Electronic catalogue policy | Not published |
| Total tender value | Not published |
| Tender lots in source | 1 |
| Tender items in source | 0 |
| Tender documents in source | 1 |
| Awards in latest release | 1 |
| Contracts in latest release | 1 |
| Parties in latest release | 4 |
| Date | Event | Reference |
|---|---|---|
| 30 Dec 2025 | award, contract | 086501-2025 |
| 28 Nov 2025 | award, contract | 078054-2025 |
| 3 Oct 2025 | tender | 061970-2025 |
| 26 Aug 2025 | planning | 051371-2025 |
Unmodified official OCDS data retained by Tenderline for this procurement process.
{
"id": "086501-2025",
"tag": [
"award",
"contract"
],
"date": "2025-12-30T16:29:54Z",
"ocid": "ocds-h6vhtk-058e04",
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"awards": [
{
"id": "2",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKC",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKD",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKF",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKG",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKH",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-11685363",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED"
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "C382504",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "NHS National Framework Agreement for Omalizumab",
"status": "complete",
"coveredBy": [
"GPA"
],
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"techniques": {
"frameworkAgreement": {
"type": "closed",
"method": "withReopeningCompetition",
"description": "Please refer to the ITO Documents for the Operation Description"
},
"hasFrameworkAgreement": true
},
"description": "Project title: NHS National Framework for Omalizumab commencing 1st February 2026 \nOffer reference number: CM/TNS/25/5734\nPeriod of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. \nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI45",
"country": "GB",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "katie.noonan@nhs.net"
}
},
{
"id": "GB-COH-11685363",
"name": "Celltrion Healthcare United Kingdom Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKI74",
"country": "GB",
"locality": "Uxbridge",
"postalCode": "UB8 1JG",
"countryName": "United Kingdom",
"streetAddress": "The Charter Building"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "11685363",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "info@celltrionhc.com"
}
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "EC2M 1QS",
"countryName": "United Kingdom",
"streetAddress": "Dashwood House"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "02619880",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "commercialsupporthospitals@advanzpharma.com"
}
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKI33",
"country": "GB",
"locality": "London",
"postalCode": "W12 7FQ",
"countryName": "United Kingdom",
"streetAddress": "2nd Floor, The Westworks Building White City Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00119006",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "commercial.pricing@novartis.com"
}
}
],
"language": "en",
"contracts": [
{
"id": "2",
"title": "Lot 1 - CM/TNS/25/5734",
"value": {
"amount": 87433000,
"currency": "GBP",
"amountGross": 104919600
},
"period": {
"endDate": "2027-08-31T23:59:59+01:00",
"startDate": "2026-02-01T00:00:00Z",
"maxExtentDate": "2029-08-31T23:59:59+01:00"
},
"status": "active",
"awardID": "2",
"renewal": {
"description": "Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months."
},
"documents": [
{
"id": "A-9646",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-9646",
"format": "application/pdf",
"description": "CONTRACT COPY Documents UK7 Contract Details Notice - CM-TNS-25-5734 Omalizumab",
"documentType": "contractSigned"
},
{
"id": "086501-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/086501-2025",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2025-12-30T16:29:54Z"
}
],
"dateSigned": "2025-12-12T00:00:00Z",
"hasRenewal": true,
"aboveThreshold": true
}
],
"initiationType": "tender"
}{
"id": "086501-2025",
"tag": [
"award",
"contract"
],
"date": "2025-12-30T16:29:54Z",
"ocid": "ocds-h6vhtk-058e04",
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"awards": [
{
"id": "2",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKC",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKD",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKF",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKG",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKH",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-11685363",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED"
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "C382504",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "NHS National Framework Agreement for Omalizumab",
"status": "complete",
"coveredBy": [
"GPA"
],
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"techniques": {
"frameworkAgreement": {
"type": "closed",
"method": "withReopeningCompetition",
"description": "Please refer to the ITO Documents for the Operation Description"
},
"hasFrameworkAgreement": true
},
"description": "Project title: NHS National Framework for Omalizumab commencing 1st February 2026 \nOffer reference number: CM/TNS/25/5734\nPeriod of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. \nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI45",
"country": "GB",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "katie.noonan@nhs.net"
}
},
{
"id": "GB-COH-11685363",
"name": "Celltrion Healthcare United Kingdom Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKI74",
"country": "GB",
"locality": "Uxbridge",
"postalCode": "UB8 1JG",
"countryName": "United Kingdom",
"streetAddress": "The Charter Building"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "11685363",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "info@celltrionhc.com"
}
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "EC2M 1QS",
"countryName": "United Kingdom",
"streetAddress": "Dashwood House"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "02619880",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "commercialsupporthospitals@advanzpharma.com"
}
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKI33",
"country": "GB",
"locality": "London",
"postalCode": "W12 7FQ",
"countryName": "United Kingdom",
"streetAddress": "2nd Floor, The Westworks Building White City Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00119006",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "commercial.pricing@novartis.com"
}
}
],
"language": "en",
"contracts": [
{
"id": "2",
"title": "Lot 1 - CM/TNS/25/5734",
"value": {
"amount": 87433000,
"currency": "GBP",
"amountGross": 104919600
},
"period": {
"endDate": "2027-08-31T23:59:59+01:00",
"startDate": "2026-02-01T00:00:00Z",
"maxExtentDate": "2029-08-31T23:59:59+01:00"
},
"status": "active",
"awardID": "2",
"renewal": {
"description": "Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months."
},
"documents": [
{
"id": "A-9646",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-9646",
"format": "application/pdf",
"description": "CONTRACT COPY Documents UK7 Contract Details Notice - CM-TNS-25-5734 Omalizumab",
"documentType": "contractSigned"
},
{
"id": "086501-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/086501-2025",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2025-12-30T16:29:54Z"
}
],
"dateSigned": "2025-12-12T00:00:00Z",
"hasRenewal": true,
"aboveThreshold": true
}
],
"initiationType": "tender"
}{
"id": "078054-2025",
"tag": [
"award",
"contract"
],
"bids": {
"details": [
{
"id": "1",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-11685363",
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "2",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED"
}
],
"relatedLots": [
"1"
]
},
{
"id": "3",
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
],
"relatedLots": [
"1"
]
}
],
"statistics": [
{
"id": "1",
"value": 3,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "2",
"value": 3,
"measure": "finalStageBids",
"relatedLot": "1"
},
{
"id": "3",
"value": 0,
"measure": "smeFinalStageBids",
"relatedLot": "1"
},
{
"id": "4",
"value": 0,
"measure": "vcseFinalStageBids",
"relatedLot": "1"
}
]
},
"date": "2025-11-28T12:23:39Z",
"ocid": "ocds-h6vhtk-058e04",
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"awards": [
{
"id": "1",
"date": "2025-11-26T00:00:00Z",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKC",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKD",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKF",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKG",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKH",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "Lot 1 - CM/TNS/25/5734",
"value": {
"amount": 87433000,
"currency": "GBP",
"amountGross": 104919600
},
"status": "pending",
"renewal": {
"description": "Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months."
},
"documents": [
{
"id": "078054-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/078054-2025",
"format": "text/html",
"noticeType": "UK6",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"datePublished": "2025-11-28T12:23:39Z"
}
],
"suppliers": [
{
"id": "GB-COH-11685363",
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED"
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED"
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
],
"hasRenewal": true,
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"status": "scheduled",
"dueDate": "2025-12-23T23:59:59Z"
}
],
"relatedLots": [
"1"
],
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-08-31T23:59:59+01:00",
"startDate": "2026-02-01T00:00:00Z",
"maxExtentDate": "2029-08-31T23:59:59+01:00"
},
"subcontracting": {
"subcontracts": [
{
"id": "1",
"description": "n/a",
"mainContractors": [
{
"id": "GB-COH-11685363",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
]
},
{
"id": "2",
"description": "n/a",
"mainContractors": [
{
"id": "GB-COH-02619880"
}
]
},
{
"id": "3",
"description": "n/a",
"mainContractors": [
{
"id": "GB-COH-00119006"
}
]
}
]
},
"standstillPeriod": {
"endDate": "2025-12-10T23:59:59+00:00"
},
"mainProcurementCategory": "goods",
"assessmentSummariesDateSent": "2025-11-28T00:00:00Z"
}
],
"tender": {
"id": "C382504",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "NHS National Framework Agreement for Omalizumab",
"status": "complete",
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"techniques": {
"hasFrameworkAgreement": true
},
"description": "Project title: NHS National Framework for Omalizumab commencing 1st February 2026 \nOffer reference number: CM/TNS/25/5734\nPeriod of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. \nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI45",
"country": "GB",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "katie.noonan@nhs.net"
}
},
{
"id": "GB-COH-11685363",
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKI74",
"country": "GB",
"locality": "Uxbridge",
"postalCode": "UB8 1JG",
"countryName": "United Kingdom",
"streetAddress": "The Charter Building"
},
"control": {
"description": "n/a"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "11685363",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "info@celltrionhc.com"
}
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKI31",
"country": "GB",
"locality": "London",
"postalCode": "EC2M 1QS",
"countryName": "United Kingdom",
"streetAddress": "Dashwood House"
},
"control": {
"description": "n/a"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "02619880",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "commercialsupporthospitals@advanzpharma.com"
}
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
"roles": [
"supplier",
"tenderer"
],
"address": {
"region": "UKI33",
"country": "GB",
"locality": "London",
"postalCode": "W12 7FQ",
"countryName": "United Kingdom",
"streetAddress": "2nd Floor, The Westworks Building White City Place"
},
"control": {
"description": "n/a"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "00119006",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "commercial.pricing@novartis.com"
}
}
],
"language": "en",
"initiationType": "tender"
}{
"id": "061970-2025",
"tag": [
"tender"
],
"date": "2025-10-03T08:53:46+01:00",
"ocid": "ocds-h6vhtk-058e04",
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"tender": {
"id": "C382504",
"lots": [
{
"id": "1",
"value": {
"amount": 85785000,
"currency": "GBP",
"amountGross": 102942000
},
"status": "active",
"renewal": {
"description": "Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months."
},
"hasRenewal": true,
"suitability": {
"sme": true
},
"awardCriteria": {
"criteria": [
{
"name": "Price is not the only award criterion",
"type": "price",
"numbers": [
{
"number": 100,
"weight": "percentageExact"
}
],
"description": "Price is not the only award criterion"
}
]
},
"contractPeriod": {
"endDate": "2027-08-31T23:59:59+01:00",
"startDate": "2026-02-01T00:00:00Z",
"maxExtentDate": "2029-08-31T23:59:59+01:00"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKC",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKD",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKF",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKG",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKH",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NHS National Framework Agreement for Omalizumab",
"value": {
"amount": 85785000,
"currency": "GBP",
"amountGross": 102942000
},
"status": "active",
"coveredBy": [
"GPA"
],
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
},
{
"id": "A-5812",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5812",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"documentType": "biddingDocuments"
},
{
"id": "A-5813",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5813",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"documentType": "biddingDocuments"
},
{
"id": "A-5814",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5814",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"documentType": "biddingDocuments"
},
{
"id": "A-5815",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5815",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"documentType": "biddingDocuments"
},
{
"id": "A-5816",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5816",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"documentType": "biddingDocuments"
},
{
"id": "A-5817",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5817",
"format": "application/xml",
"documentType": "biddingDocuments"
},
{
"id": "A-5818",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5818",
"format": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"documentType": "biddingDocuments"
},
{
"id": "A-5819",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5819",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"documentType": "biddingDocuments"
},
{
"id": "A-5820",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5820",
"format": "application/msword",
"documentType": "biddingDocuments"
},
{
"id": "A-5821",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5821",
"format": "application/vnd.ms-excel",
"documentType": "biddingDocuments"
},
{
"id": "A-5822",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5822",
"format": "application/vnd.ms-excel",
"documentType": "biddingDocuments"
},
{
"id": "A-5823",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-5823",
"format": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"documentType": "biddingDocuments"
},
{
"id": "061970-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/061970-2025",
"format": "text/html",
"noticeType": "UK4",
"description": "Tender notice on Find a Tender",
"documentType": "tenderNotice",
"datePublished": "2025-10-03T08:53:46+01:00"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"techniques": {
"frameworkAgreement": {
"type": "open",
"method": "withReopeningCompetition",
"description": "Please refer to the ITO Documents for the Operation Description",
"buyerCategories": "Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points."
},
"hasFrameworkAgreement": true
},
"awardPeriod": {
"endDate": "2025-11-26T23:59:59Z"
},
"description": "Project title: NHS National Framework for Omalizumab commencing 1st February 2026\nOffer reference number: CM/TNS/25/5734\nPeriod of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.\nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England",
"tenderPeriod": {
"endDate": "2025-10-30T13:00:00Z"
},
"enquiryPeriod": {
"endDate": "2025-10-23T13:00:00+01:00"
},
"aboveThreshold": true,
"submissionTerms": {
"languages": [
"en"
],
"electronicSubmissionPolicy": "allowed"
},
"procurementMethod": "open",
"mainProcurementCategory": "goods",
"submissionMethodDetails": "The procurement documents are available for unrestricted and full direct access, free of charge at https://health-family.force.com/s/Welcome\nAdditional info obtained from the abovementioned address\nTenders must be submitted to the abovementioned address",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI45",
"country": "GB",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "katie.noonan@nhs.net"
}
}
],
"language": "en",
"initiationType": "tender"
}{
"id": "051371-2025",
"tag": [
"planning"
],
"date": "2025-08-26T17:01:37+01:00",
"ocid": "ocds-h6vhtk-058e04",
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"tender": {
"id": "C382504",
"lots": [
{
"id": "1",
"status": "planning",
"hasRenewal": true,
"suitability": {
"sme": true
},
"contractPeriod": {
"endDate": "2027-08-31T23:59:59+01:00",
"startDate": "2026-02-01T00:00:00Z",
"maxExtentDate": "2029-08-31T23:59:59+01:00"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKC",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKD",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKF",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKG",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKH",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NHS National Framework Agreement for Omalizumab",
"value": {
"amount": 125417000,
"currency": "GBP",
"amountGross": 150500400
},
"status": "planning",
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"techniques": {
"hasFrameworkAgreement": true
},
"description": "Project title: NHS National Framework for Omalizumab commencing 1st February 2026 \nOffer reference number: CM/TNS/25/5734\nPeriod of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. \nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England",
"communication": {
"futureNoticeDate": "2025-10-01T23:59:59+01:00"
},
"aboveThreshold": true,
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI45",
"country": "GB",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"contactPoint": {
"name": "Katie Noonan",
"email": "katie.noonan@nhs.net"
}
}
],
"language": "en",
"planning": {
"documents": [
{
"id": "051371-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/051371-2025",
"format": "text/html",
"noticeType": "UK2",
"description": "Preliminary market engagement notice on Find a Tender",
"documentType": "marketEngagementNotice",
"datePublished": "2025-08-26T17:01:37+01:00"
}
],
"milestones": [
{
"id": "engagement",
"type": "engagement",
"status": "scheduled",
"dueDate": "2025-09-18T23:59:59+01:00",
"description": "NHS England is seeking to engage with suppliers that are planning to launch Omalizumab injection. Interested suppliers will be invited to a virtual PME meeting to be held on Thursday 18th September 2025\nThe purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. \nPlease contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework."
}
]
},
"initiationType": "tender"
}